Identification of appropriate in vivo models to demonstrate the phenotypic consequence of modulating the autotaxin/lysophosphatidic acid receptor (ATX/LPAR) pathway, Cancer Research Technology, Discovery Laboratories, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT.
Identification and characterisation of small molecule inhibitors of PAK4 as anti-cancer agents, RSC/SCI Protein Kinase 2012, Cambridge, UK, 21st-22nd May 2012 and Cambridge Cancer Centre Symposium, Cambridge, UK, 22nd June 2012.
Identification and characterisation of small molecule inhibitors of phosphatidylinositol-4-phosphate 5-kinase (PIP5K), Cancer Research, May 1, 2009 69; 1782, National Cancer Research Institute Conference, Birmingham, UK, October 4-7, 2009.
The discovery and optimization of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase, Bioorganic & Medicinal Chemistry Letters 19 (2009) 5950–5953.
An efficient synthesis of N-substituted[1,4]benzodioxino-[2,3-f]isoindole-1,3-diones, University of Barcelona, 11th FECHEM Conference on Heterocycles in Bio-organic Chemistry.\n